A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Some compounds found in many personal care products displace natural fat-like molecules in skin cells, which may explain how they cause an allergic skin rash.
With new microneedles in development at Columbia University, delivering precise doses of drugs to the inner ear without risking permanent hearing damage may soon be possible.
The first-ever detailed images of a malaria protein, a key modulator of drug resistance, show how the parasite evades antimalarials—and may help scientists find ways to restore the drugs’ potency.
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.